Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 7Brain Neoplasms 4Pain 2Neuralgia 2Glioma 2Depression 2Visceral Pain 1Recurrence 1Rectal Neoplasms 1Pituitary Neoplasms 1Pancreatic Neoplasms 1Neurologic Manifestations 1Lymphoma, Follicular 1Language Disorders 1Headache 1Glioblastoma 1Fatigue 1Depressive Disorder, Major 1Cognitive Dysfunction 1Carcinoma, Renal Cell 1Cancer Survivor 1Anxiety Disorders 1Agnosia 1Acromegaly 1

Interventions

Sunitinib 145Nivolumab 144pembrolizumab 132Sorafenib 84Bevacizumab 77Everolimus 74cabozantinib 71pazopanib 65Axitinib 65Ipilimumab 62aldesleukin 52Magnetic Resonance Spectroscopy 45Cyclophosphamide 40Interleukin-2 38lenvatinib 37Specimen Handling 36Radiosurgery 36Interferon-alpha 32atezolizumab 30temsirolimus 27belzutifan 24Gemcitabine 23fludarabine phosphate 22avelumab 22Radiotherapy 19Interferon alpha-2 19Biopsy 18fludarabine 17durvalumab 17Nephrectomy 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Transcranial Magnetic Stimulation × Clear all
NCT01740154 2018-12-06

Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer

Case Comprehensive Cancer Center

Phase NA Terminated
13 enrolled 7 charts
Genitourinary

Carcinoma, Renal Cell, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡